Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study

Oral Oncology

Volumn 43, Issue 10, 2007, Pages 1014-1020

  Fuwa, Nobukazu ^a   Kodaira, Takesi ^a   Furutani, Kazuhisa ^a   Tachibana, Hiroyuki ^a   Nakamura, Tatsuya ^a   Daimon, Takasi ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

CBDCA; Head and neck cancer; Intra arterial chemotherapy; Radiation therapy; Systemic chemotherapy

Indexed keywords

CARBOPLATIN; FLUOROURACIL; NEDAPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FEVER; HEAD AND NECK CANCER; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL RATE; VOMITING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; SURVIVAL RATE;

EID: 34948827416     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.11.019     Document Type: Article

References (30)

1. Sullivan R.D., Miller E., and Sikes M.P. Antimetabolite-metabolite combination cancer chemotherapy: effects of intra-arterial methotrexate-intramuscular citrovorum factor therapy in human cancer. Cancer 12 (1959) 1248-1262
2. Clarkson B., and Lawrence Jr. W. Perfusion and infusion techniques in cancer chemotherapy. J Clin North Am 45 (1961) 689-710
3. Ramsden C.H., and Duff J.K. Continuous arterial infusion of head and neck tumors. Cancer 16 (1963) 133-135
4. Jesse R.H., Goepfert H., Lindberg R.D., and Johnson R.H. Combined intra-arterial infusion and radiotherapy for the treatment of adavanced cancer of the head and neck. Am J Roentgenol Radium Ther Nucl Med 105 (1969) 20-25
5. Donegan W.L., and Harris P. Regional chemotherapy with combined drugs in cancer of the head and neck. Cancer 38 (1976) 1479-1483
6. Forastiere A.A., Baker S.R., Wheeler R., and Medvec B.R. Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck. J Clin Oncol 5 (1987) 1601-1606
7. Frustaci S., Barzan L., Caruso G., Ghirardo R., Foladore S., Carbone A., et al. Induction intra-arterial cisplatin and bleomycin in head and neck cancer. Head Neck 13 (1991) 291-297
8. Frustaci S., Barzan L., Tumolo S., Comoretto R., Quadu G., Galligioni E., et al. Intra-arterial continuous infusion of cis-diamminedichloroplatinum in untreated head and neck cancer patients. Cancer 57 (1986) 1118-1123
9. Goldsmith M.A. The integration of chemotherapy into a combined modality approach to cancer therapy. Cancer Treat Rev 2 (1975) 137-158
10. Cheung D.K., Regan J., Savin M., Gibberman V., and Woessner W. A pilot study of intraarterial chemotherapy with cisplatin in locally advanced head and neck cancers. Cancer 61 (1988) 903-908
11. Hattori T., Hirano T., Toyoda S., Nakagawa T., Yamaguchi N., and Sakakura Y. Superselective continuous intra-arterial infusion therapy via superficial temporal artery for head and neck tumors. Nippon Acta Radiologica 45 (1985) 1056-1058
12. Shimizu T., Sakakura Y., Hattori T., Yamaguchi N., Kubo M., and Sakakura K. Superselective intraarterial chemotherapy in combination with irradiation: Preliminary report. Am J Otolaryngol 11 (1990) 131-136
13. Tohnai I., Fuwa N., Hayashi Y., Kaneko R., Tomaru Y., Hibino Y., et al. New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion. Oral Oncol 34 (1998) 387-390
14. Fuwa N., Ito Y., Matsumoto A., Kamata M., Kodaira T., Furutani K., et al. A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Phase I study. Cancer 89 (2000) 2099-2105
15. Furutani K., Fuwa N., Kodaira T., Matsumoto A., Kamata M., Tachibana H., et al. Continuous selective intraarterial chemotherapy in combination with irradiation for locally advanced cancer of the tongue and tongue base. Oral Oncol 38 (2002) 145-152
16. Robbins K.T., Storniolo A.M., Kerber C., Vicario D., Seagren S., Shea M., et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 12 (1994) 2113-2120
17. Robbins K.T., Kumar P., Wong F.S., Hartsell W.F., Flick P., Palmer R., et al. Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients. Head Neck 22 (2000) 687-693
18. Paccagnella A., Orlando A., Marchiori C., et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86 (1994) 265-272
19. Schuller D.E., Metch B., Mattox D., et al. Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 98 (1988) 1205-1211
20. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324 (1991) 1685-1690
21. Laramore G.E., Scott C.B., Al-Sarraf M., et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 23 (1992) 705-713
22. Fuwa N., Kodaira T., Kamata M., Matsumoto A., Furutani K., Tachibana H., et al. Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): adverse effects and eecommended dose of NDP administered after 5-FU. Am J Clin Oncol 25 (2002) 565-569
23. In: Sobin L.H., and Wittekind Ch. (Eds). International Union Against Cancer. Fifth ed. TNM classification of malignant tumours (1997), Wiley-Liss, Inc, New York
24. WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization. 1979;14-27.
25. Kaplan E.L., and Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc 53 (1958) 475-481
26. Merlano M., Corvo R., Margarino G., Benasso M., Rosso R., Sertoli M.R., et al. Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial. Cancer 67 (1991) 915-921
27. Merlano M., Benasso M., Corvo R., Rosso R., Vitale V., Blengio F., et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88 (1996) 583-589
28. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 (2000) 949-955
29. Drewinko B., Brown B.W., and Gottlieb J.A. The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications. Cancer Res 33 (1973) 3091-3095
30. Belliveau J.F., Posner M.R., Ferrari L., Crabtree G.W., Cummings F.J., Wiemann M.C., et al. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion. Cancer Treat Rep 70 (1986) 1215-1217